Aclarion Inc. (Nasdaq: ACON, ACONW), a Broomfield health care technology company, has named Northwestern Medicine as the initial site for its CLARITY trial. This study is aimed at demonstrating the clinical and economic value of Nociscan in spine surgery, particularly for chronic low back pain. The CLARITY trial is a randomized study designed to show…